Abcam Plc (LON:ABC) insider Alan Thomas Hirzel bought 6,000 shares of the business’s stock in a transaction that occurred on Monday, March 20th. The shares were purchased at an average price of GBX 839 ($10.36) per share, for a total transaction of £50,340 ($62,171.17).

Abcam Plc (LON:ABC) opened at 831.00 on Tuesday. The firm has a 50-day moving average of GBX 865.97 and a 200 day moving average of GBX 831.16. Abcam Plc has a 52 week low of GBX 580.50 and a 52 week high of GBX 948.00. The stock’s market capitalization is GBX 1.68 billion.

The firm also recently declared a dividend, which will be paid on Thursday, April 13th. Shareholders of record on Thursday, March 16th will be issued a GBX 2.83 ($0.03) dividend. This represents a yield of 0.31%. The ex-dividend date is Thursday, March 16th.

This article was originally published by and is the sole property of American Banking News. If you happen to be reading this article on another website, it was stolen and illegally republished in violation of U.S. and International copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2017/03/21/alan-thomas-hirzel-acquires-6000-shares-of-abcam-plc-abc-stock.html

Your IP Address:

A number of analysts recently weighed in on the stock. Numis Securities Ltd lowered shares of Abcam Plc to a “hold” rating and set a GBX 912 ($11.26) target price on the stock. in a research note on Tuesday, March 7th. JPMorgan Chase & Co. restated a “neutral” rating and set a GBX 678 ($8.37) target price on shares of Abcam Plc in a research note on Tuesday, March 7th. Peel Hunt restated a “hold” rating and set a GBX 750 ($9.26) target price on shares of Abcam Plc in a research note on Monday, March 6th. Finally, Panmure Gordon restated a “sell” rating and set a GBX 680 ($8.40) target price on shares of Abcam Plc in a research note on Monday. One analyst has rated the stock with a sell rating and five have given a hold rating to the company’s stock. Abcam Plc presently has an average rating of “Hold” and a consensus target price of GBX 726 ($8.97).

About Abcam Plc

Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways.

Receive News & Ratings for Abcam Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam Plc and related companies with MarketBeat.com's FREE daily email newsletter.